Related Experiment Videos
IL-2: efficacy in renal cell carcinoma and overall safety profile
1Cetus Corporation, Emeryville, California 94608-2997.
Cancer Investigation
|January 1, 1990
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Effect of coadministration of moxifloxacin and rifampin on Mycobacterium tuberculosis in a murine aerosol infection model.
Antimicrobial agents and chemotherapy·2012
Meropenem penetration into epithelial lining fluid in mice and humans and delineation of exposure targets.
Antimicrobial agents and chemotherapy·2011
Saturability of granulocyte kill of Pseudomonas aeruginosa in a murine model of pneumonia.
Antimicrobial agents and chemotherapy·2011
Use of an in vitro pharmacodynamic model to derive a moxifloxacin regimen that optimizes kill of Yersinia pestis and prevents emergence of resistance.
Antimicrobial agents and chemotherapy·2010
Precision Pancreatic Cancer Care: From Early Detection to Adaptive Precision Oncology.
Cancer investigation·2026
Regulatory roles of pyroptosis-associated lncRnas in breast cancer progression and immune microenvironment.
Cell cycle (Georgetown, Tex.)·2026
Insights Into the Mechanisms of Biological Aging That Guide Translational and Clinical Research.
Aging medicine (Milton (N.S.W))·2026
Depletion of Soluble PD-L1 with Engineered Nanoparticles Promotes Antitumor Immunity and Tumor Control.
International journal of nanomedicine·2026
Biomaterial-based Drug delivery strategies for head and neck cancer: Local delivery, combination therapy, and translational challenges.
International journal of pharmaceutics: X·2026
Enhanced anticancer efficacy of Pa-MAP 1.9 peptide-coated silver nanostars on breast cancer cells.
Materials today. Bio·2026